OncoCyte Corporation (OCX) CEO Ronnie Andrews on Q1 2022 Results - Earning Calls TranscriptSeeking Alpha • 05/12/22
Oncocyte to Present New Data at ASCO 2022 Underpinning Pan-Cancer Clinical Utility of DetermaIO™GlobeNewsWire • 04/27/22
Oncocyte Corporation Announces Pricing of Public Offering of Common Stock and WarrantsGlobeNewsWire • 04/14/22
Oncocyte Corporation Announces Proposed Public Offering of Common Stock and WarrantsGlobeNewsWire • 04/13/22
Oncocyte Corporation Announces Pricing of Registered Direct Offering of 11,765 Shares of Series A Convertible Preferred StockGlobeNewsWire • 04/13/22
Oncocyte to Present New Data Confirming Association of IO Score with Response to Immunotherapy Treatment for Bladder Cancer at the American Association for Cancer Research Annual Meeting 2022GlobeNewsWire • 03/28/22
OncoCyte (OCX) Q4 Earnings Match Estimates, Revenues Lag (Revised)Zacks Investment Research • 03/11/22
OncoCyte Corporation (OCX) CEO Ronnie Andrews on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/11/22
Oncocyte Announces Development and Co-Marketing Agreement with Thermo Fisher Scientific to Expand Access to Precision OncologyGlobeNewsWire • 01/18/22
Spotlight Poster Presentation at San Antonio Breast Cancer Symposium SABCS 2021 Shows Oncocyte's DetermaIO™ Clinical Test Predicts Response to Immunotherapy in Triple Negative Breast CancerGlobeNewsWire • 12/09/21
Oncocyte to Present New Data on DetermaIO Clinical Test for Immunotherapy Response in Triple Negative Breast Cancer at San Antonio Breast Cancer Symposium 2021GlobeNewsWire • 12/02/21
OncoCyte's (OCX) CEO Ronnie Andrews on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
Oncocyte Announces the Clinical Launch of DetermaIO Immunotherapy Response Prediction TestGlobeNewsWire • 11/04/21
Will OncoCyte (OCX) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 11/02/21
Oncocyte Strengthens Transplant Intellectual Property Portfolio with US Patent Covering Digital PCR Technology for Early Detection of Organ Transplant RejectionGlobeNewsWire • 10/27/21
Oncocyte to Report Third Quarter 2021 Financial Results on Tuesday, November 9thGlobeNewsWire • 10/26/21
Oncocyte Publishes Study Demonstrating Predictive Potential for DetermaIO® Test in Triple Negative Breast CancerGlobeNewsWire • 09/30/21